Sandoz Inc
31 products tracked · names used in filings: Sandoz Inc, Sandoz GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
FDA approves biosimilar Enzeevu (aflibercept-abzv)
Sandoz Inc; BLA761382; Biosimilar; injectable · source
Bysumlog (insulin lispro) approved in the EU
Marketing authorisation to Sandoz GmbH; Biosimilar, Additional monitoring · source
Dazparda (insulin aspart) approved in the EU
Marketing authorisation to Sandoz GmbH; Biosimilar, Additional monitoring · source
Bysumlog (insulin lispro): CHMP positive opinion
Sandoz GmbH; Biosimilar, Additional monitoring · source
Dazparda (insulin aspart): CHMP positive opinion
Sandoz GmbH; Biosimilar, Additional monitoring · source
Ondibta (insulin glargine) approved in the EU
Marketing authorisation to Sandoz GmbH; Biosimilar, Additional monitoring · source
Ondibta (insulin glargine): CHMP positive opinion
Sandoz GmbH; Biosimilar, Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Dimherity dimethyl fumarate | Application withdrawn | |
| 🇪🇺 | Zioxtenzo pegfilgrastim | Application withdrawn | |
| 🇪🇺 | Duloxetine Sandoz duloxetine | Application withdrawn | |
| 🇺🇸 | Enzeevu aflibercept-abzv | Approved | 2026-10-22 |
| 🇪🇺 | Bysumlog insulin lispro | Authorised | 2026-05-06 |
| 🇪🇺 | Dazparda insulin aspart | Authorised | 2026-04-27 |
| 🇪🇺 | Ondibta insulin glargine | Authorised | 2026-01-09 |
| 🇪🇺 | Rolcya denosumab | Authorised | 2025-07-17 |
| 🇪🇺 | Afqlir aflibercept | Authorised | 2024-11-13 |
| 🇪🇺 | Wyost denosumab | Authorised | 2024-05-17 |
| 🇪🇺 | Jubbonti denosumab | Authorised | 2024-05-16 |
| 🇪🇺 | Herwenda trastuzumab | Authorised | 2023-11-15 |
| 🇪🇺 | Tyruko natalizumab | Authorised | 2023-09-22 |
| 🇪🇺 | Ziextenzo pegfilgrastim | Authorised | 2018-11-22 |
| 🇪🇺 | Hefiya adalimumab | Authorised | 2018-07-26 |
| 🇪🇺 | Hyrimoz adalimumab | Authorised | 2018-07-26 |
| 🇪🇺 | Halimatoz adalimumab | Withdrawn | 2018-07-26 |
| 🇪🇺 | Zessly infliximab | Authorised | 2018-05-18 |
| 🇪🇺 | Erelzi etanercept | Authorised | 2017-06-23 |
| 🇪🇺 | Riximyo rituximab | Authorised | 2017-06-15 |
| 🇪🇺 | Rixathon rituximab | Authorised | 2017-06-15 |
| 🇪🇺 | Pemetrexed Sandoz pemetrexed | Withdrawn | 2015-09-18 |
| 🇪🇺 | Aripiprazole Sandoz aripiprazole | Authorised | 2015-08-20 |
| 🇪🇺 | Pregabalin Sandoz pregabalin | Authorised | 2015-06-19 |
| 🇪🇺 | Pregabalin Sandoz GmbH pregabalin | Withdrawn | 2015-06-19 |
| 🇪🇺 | Ibandronic Acid Sandoz ibandronic acid | Lapsed | 2011-07-26 |
| 🇪🇺 | Temozolomide Sandoz temozolomide | Withdrawn | 2010-03-15 |
| 🇪🇺 | Rivastigmine Sandoz rivastigmine | Authorised | 2009-12-10 |
| 🇪🇺 | Zarzio filgrastim | Authorised | 2009-02-06 |
| 🇪🇺 | Binocrit epoetin alfa | Authorised | 2007-08-28 |
| 🇪🇺 | Omnitrope somatropin | Authorised | 2006-04-12 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.